All Research Papers Published In Drugs and Clinic

Cancel

Export

Sort by: Relevance

Supplementary Content
10.7501/j.issn.1674-5515.2023.12.030

Clinical study on Shiwei Hezi Pills combined with piperazine ferulate in treatment of chronic glomerulonephritis

Dec 1, 2023
Drugs and Clinic
Lã¼, Y + 3 more

Supplementary Content
10.7501/j.issn.1674-5515.2023.11.040

Research progress on natural product-O-methyltransferase

Nov 1, 2023
Drugs and Clinic
Huang, Y + 1 more

Supplementary Content
10.7501/j.issn.1674-5515.2023.11.008

Mechanism of Ermiao Powder in treating cervical HPV infection based on network pharmacology and molecular docking

Nov 1, 2023
Drugs and Clinic
Song, W.-W + 3 more

Supplementary Content
10.7501/j.issn.1674-5515.2023.09.009

Study on inhibitory effect and mechanism of eugenol against Staphylococcus aureus and its drug-resistant bacteria that causes pressure sores

Sep 1, 2023
Drugs and Clinic
Yu, J + 5 more

Supplementary Content
10.7501/j.issn.1674-5515.2023.02.011

Determination of atractylodin, honokiol, magnolol, hesperidin, naringin, and liquiritin in Xiangsha Pingwei Granules by UPLC-MS/MS method

Feb 1, 2023
Drugs and Clinic
Jing, Y

Supplementary Content
10.7501/j.issn.1674-5515.2023.10.039

Meta-analysis of chidamide combined with standard chemotherapy in treatment of peripheral T-cell lymphoma

Jan 1, 2023
Drugs and Clinic
Zhang, M.-Y + 2 more

Supplementary Content
10.7501/j.issn.1674-5515.2022.08.031

Analysis on the distribution and drug resistance of common pathogenic bacteria in SICU of Childrenâ€™s Hospital of Nanjing Medical University from 2017 to 2021

Aug 1, 2022
Drugs and Clinic
Yang, X.-C + 3 more

Supplementary Content
10.7501/j.issn.1674-5515.2022.07.009

Consistency evaluation of dissolution of generic and original preparation of Calcium Dobesilate Tablets

Jul 1, 2022
Drugs and Clinic
Tang, J.-F + 1 more

Supplementary Content
10.7501/j.issn.1674-5515.2022.04.033

Analysis on usage of anti-gastric acid secretion drugs in Fuyang People's Hospital from 2019 to 2021

Apr 1, 2022
Drugs and Clinic
Jiao, H + 1 more

Research Article
10.7501/j.issn.1674-5515.2020.05.042

Research progress on potential application of gualou xiebai banxia decoction in prevention and treatment of COVID-19

Jan 1, 2020
Drugs and Clinic
Li He

Since December 2019, COVID-19 cases have appeared in many parts Ofthe world and the number has soared. The epidemic situation is very serious. With the participation ot'traditional Chinese medicine in China, the epidemic prevention and control effect is remarkable, highlighting the unique advantages of traditional Chinese medicine. The symptoms of severe COVID-19 are very consistent with that of chest discomfort in Chinese medicine. Gualou Xiebai Banxia decoction is the first choice for the treatment of chest discomfort. In the diagnosis and treatment programs of COVID-19 in various provinces and cities, it has been recommended to add or subtracted Gualou Xiebai Banxia decoction. In clinical practice, XiangYang Hospital of Traditional Chinese and Western Medicine has added or subtracted Gualou Xiebai Banxia decoction to cure many patients with COVID-19. The modern pharmacological effects in Gualou Xiebai Banxia decoction are reviewed in this paper. to provide theoretical basis for its prevention and treatment of COVID-19, and to provide clinical reference for the later treatment of COVID-19.